Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis

Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis

The advancement of high-throughput sequencing and genomic analysis revealed that acute lymphoblastic leukemia (ALL) is a genetically heterogeneous disease. The abundance of such genetic data in ALL can also be utilized to identify potential targets for drug discovery and even drug repurposing. We ai...

Full description

Bibliographic Details
Main Authors: Zulfan Zazuli, Lalu Muhammad Irham, Wirawan Adikusuma, Nur Melani Sari
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceuticals
Subjects:
acute lymphoblastic leukemia
bioinformatics
leukemia
drug repurposing
genetic variants
genomic network analysis
Online Access:https://www.mdpi.com/1424-8247/15/12/1562

Internet

https://www.mdpi.com/1424-8247/15/12/1562

Similar Items